Study of the risk factors for severe childhood pertussis based on hospital surveillance data

Valérie Briand1, Isabelle Bonmarin, Daniel Lévy-Bruhl

  • 1National Institute for Public Health Surveillance, Department of Infectious Diseases, 12 rue du Val d'Osne, 94415 Saint-Maurice Cedex, France. vale.briand@laposte.net

Vaccine
|August 21, 2007
PubMed

Insights

Vaccination is key to preventing severe pertussis (whooping cough) in children. Early infant vaccination and timely boosters for older children significantly reduce the risk of severe disease and hospitalization.

Area of Science:

  • Pediatric Infectious Diseases
  • Vaccinology
  • Public Health Surveillance

Background:

  • Pertussis (whooping cough) remains a significant public health concern, particularly for infants.
  • Understanding risk factors for severe pertussis is crucial for effective prevention and management.
  • The impact of vaccination status on disease severity requires ongoing investigation.

Purpose of the Study:

  • To investigate risk factors for severe childhood pertussis.
  • To specifically assess the impact of vaccination status on pertussis severity.
  • To inform vaccination strategies for infants and older children.

Main Methods:

  • Utilized data from the French national hospital-based pertussis surveillance network.
  • Analyzed factors associated with severe pertussis, including hospitalization, intensive care unit admission, assisted ventilation, and death.
  • Examined the influence of vaccination status (primary doses and boosters) and other epidemiological factors.

Main Results:

  • For infants, receiving the first pertussis vaccine dose, delayed medical consultation, and local hospital treatment were associated with decreased severe disease risk.
  • Evidence suggested increased protection with a higher number of vaccine doses administered.
  • For older children, recent booster injections and identifying the source of infection in their environment reduced hospitalization risk.

Conclusions:

  • Early initiation of the primary pertussis vaccination course in infants is strongly recommended.
  • Timely administration of booster injections is essential for protecting older children.
  • Vaccination remains a critical tool in mitigating the severity of pertussis in pediatric populations.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
Investigation of Disease Outbreaks01:23

Investigation of Disease Outbreaks

Multistate foodborne outbreaks pose significant public health risks and require meticulous investigation to identify sources and implement control measures. The Centers for Disease Control and Prevention (CDC) utilizes a dynamic seven-step process for these investigations, integrating data from laboratories, interviews, and environmental assessments to protect public health.Outbreak Detection: The detection of multistate outbreaks typically begins with PulseNet, the CDC's national laboratory...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following: